Navigation Links
Sanofi Pasteur and Statens Serum Institut Team Up Against Tuberculosis
Date:2/14/2008

Scientific Advances in Vaccine Research may Lead to Improved Vaccine

Against Leading Cause of Death in Developing Countries

LYON, France, February 14 /PRNewswire-FirstCall/ -- Sanofi pasteur, the vaccines division of the sanofi-aventis Group, announced today that it has signed a collaborative research and license agreement with the Statens Serum Institut of Denmark (SSI) for the development and marketing of a new vaccine against tuberculosis (TB), a disease that causes the death of two million people, worldwide, each year.

Under the terms of the agreement, SSI has granted sanofi pasteur a license to its technology with regard to the use of certain fusion proteins in the development of a tuberculosis vaccine. The license from SSI includes access to the Intercell IC31(R) adjuvant. If the development is successful, sanofi pasteur would manufacture the vaccine commercially.

SSI TB vaccine candidates are recombinant protein sub-units, including one currently in a Phase I clinical trial. Results from a previous study showed the SSI TB vaccine technology to provide a positive immune response. Sanofi pasteur intends to build on the successes of the SSI vaccine program.

"This agreement is a milestone for sanofi pasteur," said Wayne Pisano, President and Chief Executive Officer of sanofi pasteur, which is also working to develop a vaccine against another one of the biggest global infectious disease killers--malaria.

"The current medical arsenal is inadequate for fighting tuberculosis," Pisano continued. "Improved vaccines are desperately needed if we are to succeed in controlling this disease. Sanofi pasteur and SSI are joining forces to develop a vaccine that may have a major impact on global health by preventing a disease that currently infects one person in the world every second."(1)

According to SSI's CEO, Nils Strandberg Pedersen, M.D., this agreement is a very important step in the fight against tuberculosis
'/>"/>

SOURCE Sanofi Pasteur
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Sanofi-aventis Announces Settlement of Average Wholesale Price Civil Suits With the U.S. Department of Justice Relating to Anzemet(R)
2. Sanofi Pasteurs Investigational H5N1 Influenza Vaccine Achieves High Immune Response at low Dosage
3. Maxygen Licenses Dengue Vaccine Technology to sanofi pasteur
4. Shareholder Class Action Filed Against Sanofi-Aventis by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
5. Pasteuria Bioscience Taps New CEO David N. Duncan
6. Panacea Pharmaceuticals Announces the Availability of BC Detect(SM), a Serum- Based Diagnostic Test for Breast Cancer
7. Codexis Licenses New Drug Metabolite Profiling and Lead Diversification Technology From the California Institute of Technology
8. Kensey Nash to Present at the Sidoti Sixth Annual West Coast Emerging Growth Institutional Investor Forum Conference
9. Abaxis to Present at the Sidoti & Company Sixth Annual San Francisco Institutional Investor Forum Conference
10. Southern Research Institute Licenses Anti-Cancer Drug Compound to Virium Pharmaceuticals
11. Midwest Research Institute Launches Center for Biological Safety and Security (CBS2)

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...ewswire/ - Cytochroma today announced the appointm... Dr. Moldt will replace Mr. Ulrik Spork as the Nov...umber of Board members remains unchanged at six me... Moldt to the board and look forward to benefiting...ntinues to make progress in becoming a leading CKD...
(Date:11/24/2009)...an . , Whether it,s CD packaging, containers...cy Identification) are increasingly finding their ...abel objects or goods and identify them automatica...n read and process the data contained in the label...ction conditions of up to 100 degrees Celsius. But...
(Date:11/24/2009)...swire/--TwomoreprestigiousuniversitieshavejoinedBi...areerssiteforlifescienceprofessionals. ,, North...oard,joining28othermajorlifesciencetrainingInstitu...,isonlyforpost-graduatesinthelifesciences.Whilethe...,BioCareerCenteristheonlyonethatserveslifesciencep...
(Date:11/24/2009)...e employment grew by 29,000 jobs in October, and ...growth during the U.S. recession. However, clinics...alth systems are coming closer to having to actual...rators. , (Vocus) Novembe...wing in October despite the shedding of jobs in mo...
Breaking Biology Technology:Cytochroma Announces Appointment of Peter Moldt to Board of Directors 2Intelligence inside metal components 2Two Major Universities Join Nation's Leading Postgrad Bio Job Board 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4
...ida Ltd.,(SWX: ARPN) announces today that it has r...ood and Drug Administration (FDA) regarding its Ne...for the treatment of complicated,skin and skin str...s letter,that they cannot approve the application ...al clinical data are required to demonstrate effic...
...webinar explains the value of in situ mid IR react...ing of catalytic and other chemical reactions unde...D (PRWEB) January 19, 2009 -- METTLER TOLEDO invit... by Dr.Will Kowalchyk Reaction Monitoring of Proc...ace on April 1, 2009. , ,Monitoring reactions un...
...ry case studies illustrating the value of in situ ...amental knowledge of chemical reactions , ...2009 -- METTLER TOLEDO invites you to attend a com...mistry Using Real-Time In Situ FTIR presented by ...2009. , ,ReactIR™ real-time in situ FTIR for...
Other Biology Technology:FDA Issues Complete Response Letter for Iclaprim 2Reaction Monitoring of Processes Under Pressure Using In Situ FTIR 2
(Date:11/26/2009)...tehead researchers have developed a new type of ge...genes and proteins used by pathogens, according to...cultures genes are present in two copies: one inhe...e inactivation by mutation is therefore inefficien... copy usually remains active and takes over. , I...
(Date:11/25/2009)...es. In addition to mammalian immune systems that b...bacteriophages, viruses that kill half the bacteri...d another class of microorganisms called archaea (...eep-sea volcanic vents) manage just fine, thank yo...stem that helps protect them from many viruses and...
(Date:11/25/2009)...ssors recently received funding from the National ...ficial to understanding the environment. The three... assistant professor in the Department of Biologic...arate research projects. , His first project, ti... Functions from the Leaf to the Landscape," will e...
Breaking Biology News(10 mins):Knockouts in human cells point to pathogenic targets 2Researchers discover biological basis of 'bacterial immune system' 2Researchers discover biological basis of 'bacterial immune system' 3Kent State University professors focus research on the environment with grants totaling $890,000 2Heart disease 3A Research off the beating patch 13108 1Heart disease 3A Research off the beating patch 13108 2NYU physicists find way to explore microscopic systems through holographic video 13103 1NYU physicists find way to explore microscopic systems through holographic video 13103 2NYU physicists find way to explore microscopic systems through holographic video 13103 3May Institute National Autism Center and Automoblox Launch Cars for Classrooms Summer Charitable Campaign to Benefit Children with Autism 52162 1May Institute National Autism Center and Automoblox Launch Cars for Classrooms Summer Charitable Campaign to Benefit Children with Autism 52162 2May Institute National Autism Center and Automoblox Launch Cars for Classrooms Summer Charitable Campaign to Benefit Children with Autism 52162 3May Institute National Autism Center and Automoblox Launch Cars for Classrooms Summer Charitable Campaign to Benefit Children with Autism 52162 4
...,the disease systemic lupus erythematosus (SLE) ha...by researchers at the Department of Medical,Scienc...ublished today,on the Web page of the highly prest...findings are probably the first genetic pieces of ...l be possible to,discover the mechanisms behind th...
...as modulated only by transcription factors. Then w...could be regulated by the RISC complex (siRNA-medi... regulation at the RNA level is even more complex ...ideo game player knows, the first requirement for ... different for cell biologists and clinicians who ...
..., yet their evolutionary history is largely unknow...ng or incomplete theories about their origins and ...ersity of California, Riverside Biology Professor ...8 issue of the journal Science that uses molecular...e gaps. , Springer coauthors the paper, titled A M...
Other Biology News:Genes In The Interferon System Important In Systemic Lupus Erythematosus 2FDA Approves Human Hookworm Vaccine for Phase I Safety Trials 2FDA Approves Human Hookworm Vaccine for Phase I Safety Trials 3Molecular biology fills gaps in knowledge of bat evolution 2
...d stackable multi-function incubator. It uses a mi...n to accurately control temperature and agitation ... temperature in the incubator. Temperature can be ...er. Built in maintenance-free stepping motor for h...
PCR Optimization Kit; Kit for optimization of PCR from Roche Applied Science
...ns is designed for laboratories with limited space...or routine sample preparation and for automation o...put, process consistency and safety. Windows NT b...ntrol the robotic and liquid handling functions an...
Mouse Anti-Human CDC2L5 Monoclonal Antibody, Unconjugated, Clone 1B3-1B11 from Novus Biologicals
Biology Products: